Chicago Partners Investment »

Taysha Gene Therapies shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2024-09-30 $233k 118k 1.97
2024-06-30 $263k 117k 2.25
2024-03-31 $317k 125k 2.53
2023-12-31 $198k 135k 1.47
2023-09-30 $242k 111k 2.18

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Equity Market (DFUS)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Mcp Etf (IJH)
Enterprise Products Partners (EPD)
Apple (AAPL)
Energy Transfer Com Ut Ltd Ptn (ET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Innovator Etfs Trust Quity Managd Flr (SFLR)
Ishares Tr Rus Mdcp Val Etf (IWS)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Small Cap Etf (DFAS)

View all positions for Chicago Partners Investment

Top funds holding Taysha Gene Therapies

BlackRock
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Taysha Gene Therapies